Spinal Muscular Atrophy Heat Shock Treatment for SMN2 Splicing
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current therapies for spinal muscular atrophy (SMA) focus on stabilizing SMN protein, increasing transcription rate, or altering splicing of SMN2 mRNA, but fail to effectively increase full-length SMN protein levels due to mis-splicing of exon 7, leading to non-functional truncated proteins.
Innovation Solution
Induce a heat shock response in subjects using heat shock inducing agents or conditions, such as protein synthesis inhibitors, proteasome inhibitors, or heating tissues above 37°C, to modulate SMN2 splicing and increase full-length SMN2 mRNA and protein levels.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Quantity of substance
If SMN2 transcription rate is increased, then more SMN2 mRNA is produced, but mis-splicing of exon 7 still occurs leading to truncated non-functional proteins
Solution Approach 1:
The patent applies parameter changes by using heat shock (temperature parameter) and chemical agents to alter the splicing parameters of SMN2 mRNA. The heat shock response changes the cellular environment parameters, affecting splicing factor activity and RNA polymerase II phosphorylation, thereby improving exon 7 inclusion without changing the DNA sequence or transcription rate parameters.
Solution Approach 2:
The patent uses heat shock proteins and splicing factors as intermediaries to mediate between the applied stress (heat/chemical) and the SMN2 splicing outcome. These intermediary proteins transmit the signal from the stress condition to the splicing machinery, facilitating correct exon 7 inclusion in SMN2 transcripts.
2Quantity of substance
If protein synthesis inhibitors are used to induce heat shock response, then full-length SMN2 protein increases, but protein synthesis is temporarily inhibited
Solution Approach 1:
The patent employs periodic action by using transient treatment with protein synthesis inhibitors or heat shock for specific time periods (e.g., 2-24 hours), followed by recovery periods. This periodic stress-induction and recovery cycle allows accumulation of full-length SMN2 protein during treatment phases while maintaining overall protein synthesis capacity during recovery phases.
Solution Approach 2:
The patent changes the temporal parameters of protein synthesis by temporarily inhibiting it during heat shock induction, then allowing recovery. This parameter change in synthesis timing creates a window where splicing is corrected without permanent loss of protein production capacity.
3Manufacturing precision
If heating tissue above 37°C is applied, then SMN2 splicing is corrected, but thermal damage may occur to sensitive tissues
Solution Approach 1:
The patent applies partial action by using moderate heat shock temperatures (39-42°C) for limited durations (2-24 hours) rather than extreme temperatures. This partial thermal stress is sufficient to induce heat shock response and correct splicing without causing severe thermal damage to tissues. The treatment is applied locally to target tissues rather than systemically.
Solution Approach 2:
The patent employs prior cushioning by pre-conditioning cells or tissues with gradual temperature increase or by co-administering heat shock protecting agents before the main heat shock treatment. This preparatory step cushions the tissue against excessive thermal damage while maintaining the splicing-correction benefit.
4Manufacturing precision
If multiple heat shock inducing agents are combined, then splicing correction is enhanced, but treatment complexity increases
Solution Approach 1:
The patent merges multiple heat shock inducing agents (e.g., protein synthesis inhibitors, proteasome inhibitors, chemical chaperones) into combination therapies that synergistically enhance splicing correction. By combining agents that act through different mechanisms but converge on heat shock response activation, the patent achieves enhanced splicing correction without requiring complex multi-step protocols.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The heat shock response significantly increases full-length SMN2 mRNA and protein by at least 50% in neural and muscle cells, potentially alleviating SMA symptoms by correcting splicing defects and enhancing functional SMN protein production.
Implementation Method 1
inducing a heat shock response in a subject in need thereof... Administration of the heat shock inducing agent increases full length SMN2 mRNA and full length SMN2 protein in neural cells, muscle cells, or glial cells of the subject
Implementation Method 2
the heat shock response is induced by heating the temperature of a tissue region of the subject above 37° C.
Data Source
AI summary
A method of treating spinal muscular atrophy by inducing a heat shock response in a subject in need thereof is described. The heat shock response can be induced by heating the temperature of a tissue region of the subject above 37° C. or by administering a therapeutically effective amount of a heat shock inducing agent.